Westin Acquisition Corp and First Choice Healthcare Solutions Announce Definitive \$650 Million Business Combination
Key Points for Investors
- Business Combination: Westin Acquisition Corp (Nasdaq: WSTN) and First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) have signed a definitive merger agreement. The transaction will result in First Choice rebranding as Wellgevity 360, a next-generation healthcare and wellness platform focused on longevity, preventative care, and personalized, biology-driven treatment solutions.
- Valuation: The transaction values First Choice Healthcare at a pro forma enterprise value of approximately \$650 million.
- Market Opportunity: The U.S. wellness economy is valued at \$2.1 trillion, growing at an annual rate of 7.9% (2019-2024). Per capita wellness spending in the U.S. crossed \$6,000 in 2024, representing 7.33% of GDP. Globally, the wellness economy reached \$6.8 trillion and is projected to approach \$9.8 trillion by 2029, growing at a 7.6% annual rate.
- Business Model: First Choice operates functional health, longevity, and regenerative medicine clinics, integrating primary care, advanced diagnostics, regenerative therapies, medical weight loss, and hormone optimization. The company targets cash-pay, membership programs, and high-income demographics, potentially creating durable, recurring, and compounding revenue streams.
- Strategic Expansion: The merger will provide First Choice with public market access, resources, and strategic flexibility to scale its national footprint, invest in health tech, and expand its patient base.
- Leadership: Both companies are led by experienced management teams with backgrounds in healthcare services, biopharmaceuticals, and emerging growth sectors.
- Post-Combination: The merged company, Wellgevity 360, Inc., is expected to trade on Nasdaq. The closing is anticipated in Q4 2026, subject to shareholder and regulatory approvals.
Details Investors Should Not Miss
- Transaction Structure: Westin will domesticate from the Cayman Islands to Nevada, after which its subsidiary will merge with First Choice, making First Choice a wholly owned subsidiary of the new public entity, Wellgevity 360, Inc.
- Regulatory & Shareholder Approvals: The deal requires approval from shareholders of both Westin and First Choice, SEC effectiveness of the registration statement (Form F-4), and Nasdaq listing approval.
- Potential Risks: Risks include failure to gain shareholder or regulatory approval, changes to transaction structure required by law, disruption to current operations, inability to realize anticipated synergies, competition, and retention of management/key employees. Legal proceedings post-announcement and changes in laws/regulations could also impact outcomes.
- Forward-Looking Statements: The press release contains forward-looking statements subject to uncertainties and risks, including market conditions, ability to scale, and execution of growth plans.
- Financial Advisors & Legal Counsel: Advisors named include Celine & Partners, PLLC and Ogier (legal for Westin); Sichenzia Ross Ference Carmel LLP (U.S. securities counsel for First Choice); Geneva Capital Pte. Ltd. (financial advisor for First Choice).
- Shareholder Communication: All shareholders will receive proxy statements/prospectus. No securities will be offered except via a prospectus meeting SEC requirements.
- Significant Growth Potential: Management highlights the opportunity to capitalize on the fast-growing longevity and wellness markets, driven by trends in genomics, nutraceuticals, AI-powered precision medicine, and the shift of med-spas toward holistic longevity centers.
- Cash-Pay Model & Memberships: Reduced insurance dependency and predictable recurring revenue may make the business model more durable and attractive to investors.
- Price Sensitivity: The \$650 million valuation, rebranding, and Nasdaq listing are major developments likely to affect share values, especially upon successful completion and subsequent growth announcements.
Additional Information and Contacts
Investors are urged to read all SEC filings, including the Registration Statement on Form F-4, proxy statement/prospectus, and other transaction-related materials as they become available. Free copies will be accessible via www.sec.gov or by written request to Westin Acquisition Corp.
Contacts:
Westin Acquisition Corp.: Bob Lau ([email protected])
First Choice Healthcare Solutions, Inc.: Kevin McGrath, PCG Advisory (+1-646-418-7002, [email protected])
Disclaimer
This article is for informational purposes only and does not constitute an offer to sell or solicitation of an offer to buy any securities. The information is based on the press release and related filings and may contain forward-looking statements subject to risks and uncertainties. Investors should carefully review all SEC filings and consult with financial advisors before making any investment decisions. Past performance is not indicative of future results.
